卒中取栓术后患者报告的健康相关生活质量:临床实践研究
该前瞻性观察研究纳入504例连续接受取栓治疗的卒中患者,于90天用EQ-5D评估患者报告的健康相关生活质量(HRQOL),平均EQ-5D-I评分为0.39(SD 0.44)。运动功能相关领域抱怨最多,较低年龄、较低病前mRS、较低基线NIHSS、较高ASPECTS、联合溶栓及成功再通是更好HRQOL的独立预测因素。
要点
- 取栓术后90天平均EQ-5D-I评分为0.39,运动功能领域抱怨最频繁。
- 较低年龄、较低病前mRS和基线NIHSS、较高ASPECTS预测更好HRQOL。
- 联合溶栓和成功再通也是更好HRQOL的独立预测因素。
核心结论
- 患者报告的HRQOL比mRS评分能更全面地评估卒中结局。
- 取栓术后HRQOL中运动功能领域抱怨最频繁,但大部分患者未报告任何抱怨。
- 更好HRQOL的预测因素与其他取栓研究中更好功能结局的预测因素高度一致。
研究设计与样本
- 90天时用改良Rankin量表(mRS)评估功能结局,用EuroQol五维问卷(EQ-5D)评估患者报告的HRQOL。
- 计算EQ-5D效用指数(EQ-5D-I,范围-0.594至1.00,越高表示HRQOL越好),用线性回归分析寻找更好HRQOL的预测因素。
主要发现
- 504例患者中位年龄76岁,女性占51.8%,平均EQ-5D-I评分为0.39(SD 0.44)。
- 卒中幸存者报告各领域抱怨的比例从日常活动66%降至移动57%、自理50.4%、疼痛/不适41.7%、焦虑/抑郁40.8%。
- 较低年龄、较低病前mRS评分、较低基线NIHSS评分、较高ASPECTS、联合溶栓治疗和成功再通是更好HRQOL的独立预测因素。
关键数值与推荐
- EQ-5D-I评分范围-0.594至1.00,越高表示HRQOL越好,本队列平均为0.39(SD 0.44)。
- 各健康领域抱怨比例:日常活动66%、移动57%、自理50.4%、疼痛/不适41.7%、焦虑/抑郁40.8%。
临床怎么用
- 取栓术后评估应结合患者报告的HRQOL(如EQ-5D),以更全面反映卒中结局。
- 关注运动功能相关健康领域,因其抱怨最频繁。
- 较低年龄、较低病前mRS和基线NIHSS、较高ASPECTS、联合溶栓及成功再通提示更好HRQOL。
局限性
- 单中心观察性研究,结果外推需谨慎。
- 仅报告90天HRQOL,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine patient-reported health-related quality of life (HRQOL) after stroke thrombectomy in clinical practice and to identify predictors of better HRQOL by analyzing data of 504 consecutive patients treated in a large university stroke center. METHODS: All patients with stroke treated by thrombectomy (June 2015-October 2018) were prospectively enrolled in this observational study. At 90 days, functional outcome was assessed by the modified Rankin Scale (mRS) and patient-reported HRQOL was assessed by the EuroQol Group 5-Dimension (EQ-5D) self-report questionnaire, consisting of 5 health domains. The EQ-5D utility index (EQ-5D-I) score (-0.594 to 1.00, with higher values indicating better HRQOL) was calculated. Linear regression analysis was applied to identify predictors of better HRQOL (higher EQ-5D-I score). RESULTS: Of 504 patients (median age 76 years, 51.8% female), the mean EQ-5D-I score was 0.39 (SD 0.44). The proportion of stroke survivors who reported complaints in the different domains decreased from 66% in Usual Activities to 57% in Mobility, 50.4% in Self-Care, 41.7% in Pain/Discomfort, and 40.8% Anxiety/Depression. Lower age, lower prestroke mRS score, lower baseline NIH Stroke Scale score, higher Alberta Stroke Program Early CT Score, concomitant thrombolysis therapy, and a successful recanalization were independent predictors of better HRQOL. CONCLUSIONS: Patient-reported HRQOL provides a more comprehensive assessment of stroke outcome than the mRS score. Health domains involving motor function most frequently showed complaints in HRQOL after stroke thrombectomy, while a large proportion of patients did not report any complaints across the different health domains. Predictors of better HRQOL closely match the predictors of better functional outcome measured by the mRS in other thrombectomy studies.
引用
- Deb-Chatterji M, Konnopka A, Flottmann F, et al. Patient-reported, health-related, quality of life after stroke thrombectomy in clinical practice. Neurology. 2020. PMID: 32680947. doi:10.1212/WNL.0000000000010356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。